US Stock MarketDetailed Quotes
BNOX Bionomics
- 1.000
- +0.034+3.49%
Close Apr 26 16:00 ET
- 1.020
- +0.020+2.00%
Post 19:59 ET
10.69MMarket Cap-370P/E (TTM)
1.000High0.934Low45.06KVolume0.990Open0.966Pre Close43.77KTurnover0.64%Turnover RatioLossP/E (Static)10.69MShares6.41052wk High0.56P/B7.09MFloat Cap0.87052wk Low--Dividend TTM7.09MShs Float22.000Historical High--Div YieldTTM6.87%Amplitude0.870Historical Low0.971Avg Price1Lot Size
Bionomics Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (Q3)Mar 31, 2022 | (Q2)Dec 31, 2021 | (Q1)Sep 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 1.89%-21.34M | -188.58%-21.76M | ||||||||
| Net income from continuing operations | -46.36%-31.85M | ---- | ---- | ---- | ---- | -150.19%-21.76M | ---- | ---- | ---- | ---- |
| Operating gains losses | -104.53%-33.56K | ---- | ---- | ---- | ---- | 170.72%740.25K | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 4.29%1.16M | ---- | ---- | ---- | ---- | -34.77%1.11M | ---- | ---- | ---- | ---- |
| Other non cash items | -45.12%508.45K | ---- | ---- | ---- | ---- | 138.01%926.49K | ---- | ---- | ---- | ---- |
| Change In working capital | 224.37%6.97M | ---- | ---- | ---- | ---- | -443.00%-5.6M | ---- | ---- | ---- | ---- |
| -Change in receivables | 205.33%6.14M | ---- | ---- | ---- | ---- | -387.86%-5.83M | ---- | ---- | ---- | ---- |
| -Change in payables and accrued expense | -27.11%714.21K | ---- | ---- | ---- | ---- | 1,647.91%979.9K | ---- | ---- | ---- | ---- |
| -Change in other current assets | 143.02%258.25K | ---- | ---- | ---- | ---- | -600.87%-600.29K | ---- | ---- | ---- | ---- |
| -Change in other working capital | 2.38%-147.16K | ---- | ---- | ---- | ---- | 38.05%-150.75K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 1.89%-21.34M | ---- | ---- | ---- | ---- | -188.58%-21.76M | ---- | ---- | ---- | ---- |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -22.87%479.53K | -53.61%288.43K | 0 | -56.50%191.1K | 0 | 875.13%621.7K | 563.96%621.7K | -2K | 2,484.21%439.32K | 430.30%175K |
| Net PPE purchase and sale | --0 | ---- | --0 | ---- | --0 | 407.95%173.55K | --173.55K | ---175.09K | ---- | ---- |
| Net intangibles purchase and sale | ---- | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Net business purchase and sale | ---- | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | --0 | ---- | --0 | ---- | --0 | 467.73%435.64K | --435.64K | ---435.64K | ---- | ---- |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---2K | ---- | 430.30%175K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -22.87%479.53K | -53.61%288.43K | --0 | -56.50%191.1K | --0 | 875.13%621.7K | 563.96%621.7K | ---2K | 2,484.21%439.32K | 430.30%175K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -79.42%5.56M | -100.43%-91.55K | -107.86%-306K | -76.75%5.99M | 96.77%-39K | -14.45%27M | 69.43%21.35M | -76.93%3.89M | 7,982.40%25.78M | -147.47%-1.21M |
| Net issuance payments of debt | 8.14%-160.04K | 25.82%-40.96K | -99.02%-40K | -8.60%-40.08K | 37.10%-39K | 98.53%-174.22K | 99.32%-55.22K | 98.87%-20.1K | 97.05%-36.9K | ---62K |
| Net common stock issuance | -77.44%7.42M | ---- | ---- | -74.09%7.42M | --0 | -24.97%32.89M | 22.39%25.47M | -77.39%4.22M | 1,523.57%28.64M | -98.95%27K |
| Cash dividends paid | ---- | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
| Net other financing activities | 70.24%-1.7M | 98.76%-50.59K | 20.12%-266K | ---- | ---- | -1,276.87%-5.72M | -2,630.62%-4.07M | -776.32%-333K | -1,361.13%-2.82M | -3,158.33%-1.17M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -79.42%5.56M | -100.43%-91.55K | -107.86%-306K | -76.75%5.99M | 96.77%-39K | -14.45%27M | 69.43%21.35M | -76.93%3.89M | 7,982.40%25.78M | -147.47%-1.21M |
| Net cash flow | ||||||||||
| Beginning cash position | 17.77%33.56M | 0.00%22.45M | -23.92%30.7M | 41.76%31.43M | 17.78%33.57M | 522.56%28.5M | 10.35%22.45M | 603.00%40.35M | 420.71%22.17M | 522.52%28.5M |
| Current changes in cash | -361.13%-15.31M | -124.71%-4.19M | -3,508.68%-8.25M | -97.76%417.58K | 47.95%-3.28M | -75.51%5.86M | 106.62%16.97M | -98.34%242K | 1,102.71%18.65M | -1,622.40%-6.3M |
| Effect of exchange rate changes | 99.04%-7.63K | 99.55%-3.55K | 99.90%-1K | -142.18%-1.15M | 5,086.96%1.15M | -5,991.71%-796.43K | -1,220.72%-792.43K | -1,653.85%-1.01M | -588.24%-474.89K | -150.00%-23K |
| End cash Position | -45.63%18.25M | -45.63%18.25M | -43.29%22.45M | -23.92%30.7M | 41.76%31.43M | 17.77%33.56M | 17.78%33.56M | 94.57%39.58M | 602.99%40.35M | 420.71%22.17M |
| Free cash flow | 1.90%-21.34M | 12.12%-4.39M | -117.80%-7.94M | 23.80%-5.77M | 38.49%-3.24M | -188.55%-21.76M | -17.55%-5M | -56.52%-3.65M | -722.89%-7.57M | -79.04%-5.27M |
| Currency Unit | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg